ITOS – ITeos Therapeutics Inc
Float Short %
6.95
Margin Of Safety %
Put/Call OI Ratio
1.02
EPS Next Q Diff
1.29
EPS Last/This Y
-0.52
EPS This/Next Y
1.15
Price
10.2
Target Price
10.3
Analyst Recom
3
Performance Q
17.26
Relative Volume
0.66
Beta
1.31
Ticker: ITOS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | ITOS | 10.18 | 1.03 | 10.88 | 26374 |
| 2025-07-28 | ITOS | 10.12 | 1.05 | 0.00 | 26698 |
| 2025-07-29 | ITOS | 10.12 | 0.96 | 7.84 | 25593 |
| 2025-07-30 | ITOS | 10.12 | 0.97 | 0.00 | 25916 |
| 2025-07-31 | ITOS | 10.14 | 0.97 | 0.16 | 25987 |
| 2025-08-01 | ITOS | 10.1 | 0.92 | 20.14 | 26940 |
| 2025-08-04 | ITOS | 10.09 | 0.93 | 3.78 | 27085 |
| 2025-08-05 | ITOS | 10.1 | 0.94 | 10.00 | 27385 |
| 2025-08-06 | ITOS | 10.1 | 0.94 | 999.99 | 27418 |
| 2025-08-07 | ITOS | 10.12 | 0.96 | 0.00 | 27692 |
| 2025-08-08 | ITOS | 10.11 | 0.95 | 999.99 | 27745 |
| 2025-08-11 | ITOS | 10.11 | 0.95 | 999.99 | 27755 |
| 2025-08-12 | ITOS | 10.1 | 0.96 | 0.46 | 27807 |
| 2025-08-13 | ITOS | 10.13 | 0.97 | 0.00 | 27633 |
| 2025-08-14 | ITOS | 10.12 | 1.02 | 0.00 | 26892 |
| 2025-08-15 | ITOS | 10.11 | 1.02 | 0.01 | 26890 |
| 2025-08-18 | ITOS | 10.11 | 1.03 | 0.24 | 24240 |
| 2025-08-19 | ITOS | 10.13 | 1.02 | 2.26 | 24345 |
| 2025-08-20 | ITOS | 10.2 | 1.02 | 4.00 | 24513 |
| 2025-08-21 | ITOS | 10.2 | 1.02 | 0.73 | 24528 |
| 2025-08-22 | ITOS | 10.2 | 1.02 | 0.38 | 24696 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | ITOS | 10.17 | -342.4 | - | -3.34 |
| 2025-07-28 | ITOS | 10.12 | -358.3 | - | -3.34 |
| 2025-07-29 | ITOS | 10.11 | -358.3 | - | -3.34 |
| 2025-07-30 | ITOS | 10.12 | -358.3 | - | -3.34 |
| 2025-07-31 | ITOS | 10.14 | -358.3 | - | -3.34 |
| 2025-08-01 | ITOS | 10.09 | -358.3 | - | -3.34 |
| 2025-08-04 | ITOS | 10.10 | -358.3 | - | -3.34 |
| 2025-08-05 | ITOS | 10.11 | -358.3 | - | -3.34 |
| 2025-08-06 | ITOS | 10.11 | -358.3 | - | -3.34 |
| 2025-08-07 | ITOS | 10.13 | -358.3 | - | -3.34 |
| 2025-08-08 | ITOS | 10.11 | -358.3 | - | -3.34 |
| 2025-08-11 | ITOS | 10.12 | 2.9 | - | -3.34 |
| 2025-08-12 | ITOS | 10.11 | 2.9 | - | -3.34 |
| 2025-08-13 | ITOS | 10.12 | 2.9 | - | -3.34 |
| 2025-08-14 | ITOS | 10.12 | 2.9 | - | -3.34 |
| 2025-08-15 | ITOS | 10.11 | 2.9 | - | -3.84 |
| 2025-08-18 | ITOS | 10.10 | 2.9 | - | -3.84 |
| 2025-08-19 | ITOS | 10.13 | 2.9 | - | -3.84 |
| 2025-08-20 | ITOS | 10.21 | 2.9 | - | -3.84 |
| 2025-08-21 | ITOS | 10.20 | 2.9 | - | -3.84 |
| 2025-08-22 | ITOS | 10.20 | 2.9 | - | -3.84 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | ITOS | 0 | 32.06 | 8.56 |
| 2025-07-28 | ITOS | 0 | 23.58 | 8.56 |
| 2025-07-29 | ITOS | 0 | 23.58 | 8.56 |
| 2025-07-30 | ITOS | 0 | 23.58 | 8.56 |
| 2025-07-31 | ITOS | 0 | 23.58 | 8.56 |
| 2025-08-01 | ITOS | 0 | 23.58 | 8.56 |
| 2025-08-04 | ITOS | 0 | 25.83 | 8.56 |
| 2025-08-05 | ITOS | 0 | 25.83 | 8.56 |
| 2025-08-06 | ITOS | 0 | 25.83 | 8.56 |
| 2025-08-07 | ITOS | 0 | 25.83 | 8.56 |
| 2025-08-08 | ITOS | 0 | 25.83 | 8.56 |
| 2025-08-11 | ITOS | 480.50 | 26.18 | 0 |
| 2025-08-12 | ITOS | 480.50 | 26.18 | 7.16 |
| 2025-08-13 | ITOS | 480.50 | 26.18 | 7.16 |
| 2025-08-14 | ITOS | 480.55 | 26.18 | 7.16 |
| 2025-08-15 | ITOS | 480.51 | 26.18 | 7.16 |
| 2025-08-18 | ITOS | 480.50 | 20.62 | 6.95 |
| 2025-08-19 | ITOS | 153.76 | 20.62 | 6.95 |
| 2025-08-20 | ITOS | 153.76 | 20.62 | 6.95 |
| 2025-08-21 | ITOS | 153.76 | 20.62 | 6.95 |
| 2025-08-22 | ITOS | 153.76 | 20.62 | 6.95 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.51
Avg. EPS Est. Current Quarter
-1.02
Avg. EPS Est. Next Quarter
-0.22
Insider Transactions
153.76
Institutional Transactions
20.62
Beta
1.31
Average Sales Estimate Current Quarter
-6
Average Sales Estimate Next Quarter
Fair Value
Quality Score
8
Growth Score
22
Sentiment Score
42
Actual DrawDown %
80.6
Max Drawdown 5-Year %
-89.5
Target Price
10.3
P/E
Forward P/E
PEG
P/S
P/B
0.91
P/Free Cash Flow
EPS
-4.85
Average EPS Est. Cur. Y
-3.84
EPS Next Y. (Est.)
-2.68
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.66
Return on Equity vs Sector %
-65.7
Return on Equity vs Industry %
-52.8
EPS 1 7Days Diff
-0.5
EPS 1 30Days Diff
-0.5
EBIT Estimation
iTeos Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 173
iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of T-cell immunoreceptor with Ig and ITIM domains (TIGIT), as well as engages the Fc gamma receptor to activate dendritic cells, natural killer cells, T lymphocytes, and macrophages and to promote the release of cytotoxic granules and antibody-dependent cellular cytotoxicity activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonist program; EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to reverse immunosuppression and restore T cell proliferation in the tumor microenvironment; and EOS-215, a monoclonal antibody which antagonizes triggering receptor expressed on triggering receptor expressed on myeloid cells 2. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.
stock quote shares ITOS – ITeos Therapeutics Inc Stock Price stock today
news today ITOS – ITeos Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ITOS – ITeos Therapeutics Inc yahoo finance google finance
stock history ITOS – ITeos Therapeutics Inc invest stock market
stock prices ITOS premarket after hours
ticker ITOS fair value insiders trading